| PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers in pharmacology 8, 561, 2017 | 1642 | 2017 |
| Recent developments and biological activities of thiazolidinone derivatives: A review AK Jain, A Vaidya, V Ravichandran, SK Kashaw, RK Agrawal Bioorganic & medicinal chemistry 20 (11), 3378-3395, 2012 | 512 | 2012 |
| siRNA delivery strategies: a comprehensive review of recent developments K Tatiparti, S Sau, SK Kashaw, AK Iyer Nanomaterials 7 (4), 77, 2017 | 467 | 2017 |
| CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4 (3H)-ones V Jatav, P Mishra, S Kashaw, JP Stables European journal of medicinal chemistry 43 (9), 1945-1954, 2008 | 343 | 2008 |
| Synthesis and CNS depressant activity of some novel 3-[5-substituted 1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4 (3H)-ones V Jatav, P Mishra, S Kashaw, JP Stables European journal of medicinal chemistry 43 (1), 135-141, 2008 | 249 | 2008 |
| Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea SK Kashaw, V Kashaw, P Mishra, NK Jain, JP Stables European Journal of Medicinal Chemistry 44 (11), 4335-4343, 2009 | 175 | 2009 |
| Advances in antibody–drug conjugates: A new era of targeted cancer therapy S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer Drug Discovery Today 22 (10), 1547-1556, 2017 | 164 | 2017 |
| Synthesis and antimicrobial activity of some new 3–[5-(4-substituted) phenyl-1, 3, 4-oxadiazole-2yl]-2-styrylquinazoline-4 (3H)-ones V Gupta, SK Kashaw, V Jatav, P Mishra Medicinal Chemistry Research 17 (2), 205-211, 2008 | 143 | 2008 |
| Comprehensive review on various strategies for antimalarial drug discovery M Mishra, VK Mishra, V Kashaw, AK Iyer, SK Kashaw European journal of medicinal chemistry 125, 1300-1320, 2017 | 137 | 2017 |
| Fabrication of Apigenin loaded gellan gum–chitosan hydrogels (GGCH-HGs) for effective diabetic wound healing R Shukla, SK Kashaw, AP Jain, S Lodhi International journal of biological macromolecules 91, 1110-1119, 2016 | 117 | 2016 |
| Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach K Bhise, SK Kashaw, S Sau, AK Iyer International journal of pharmaceutics 526 (1-2), 506-515, 2017 | 99 | 2017 |
| Synthesis of novel 2, 5‐disubstituted 1, 3, 4‐thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies H Rajak, R Deshmukh, N Aggarwal, S Kashaw, MD Kharya, P Mishra Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2009 | 97 | 2009 |
| Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and … P Sahu, SK Kashaw, S Jain, S Sau, AK Iyer Journal of Controlled Release 253, 122-136, 2017 | 94 | 2017 |
| Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers KA Gawde, S Sau, K Tatiparti, SK Kashaw, M Mehrmohammadi, AS Azmi, ... Colloids and Surfaces B: Biointerfaces 167, 8-19, 2018 | 89 | 2018 |
| Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones SK Kashaw, V Gupta, V Kashaw, P Mishra, JP Stables, NK Jain Medicinal chemistry research 19, 250-261, 2010 | 88 | 2010 |
| pH responsive 5-fluorouracil loaded biocompatible nanogels for topical chemotherapy of aggressive melanoma P Sahu, SK Kashaw, S Sau, V Kushwah, S Jain, RK Agrawal, AK Iyer Colloids and Surfaces B: Biointerfaces 174, 232-245, 2019 | 76 | 2019 |
| pH responsive biodegradable nanogels for sustained release of bleomycin P Sahu, SK Kashaw, V Kushwah, S Sau, S Jain, AK Iyer Bioorganic & medicinal chemistry 25 (17), 4595-4613, 2017 | 72 | 2017 |
| Synthesis of 1, 3, 5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents VK Mishra, M Mishra, V Kashaw, SK Kashaw Bioorganic & Medicinal Chemistry 25 (6), 1949-1962, 2017 | 72 | 2017 |
| PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561 HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers Media SA DOI 10, 2017 | 70 | 2017 |
| Nanomedicine for cancer diagnosis and therapy: Advancement, success and structure–activity relationship K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer Therapeutic delivery 8 (11), 1003-1018, 2017 | 62 | 2017 |
